Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds



Signal Detection throughout the Product Life Cycle

Posted on: 07 May 04


Learn innovative ways to analyze data derived from signals in clinical development as well as post-maketing surveillance.

Pharmaceutical Education Associates Presents:


Signal Detection throughout the Product Life Cycle

Philadelphia, PA – The Park Hyatt Philadelphia at the BellevueJuly 14-16, 2004


Pharmaceutical companies have been tracking adverse events, drug reactions and drug safety issues for years.  Now, the most successful companies are implementing innovative methods and ways of data mining into complex, multi-faceted databases to proactively identify and analyze signals that occur not only in post-marketing surveillance, but in all phases of drug development as well. 


Even the regulatory agencies like the FDA are developing new recommendations for analyzing data that will help in identifying signals earlier – even in early clinical development.  Pharmaceutical companies must keep in pace with these new developments or risk being identified by the regulators as non-compliant and not up to current standards. 


Based on our carefully conducted research, now is the best time to develop new signal detection approaches and the most innovative ways are addressed at this event. 

Jennifer McGinnis

Last updated on: 27/08/2010 11:40:18

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.